Turmeric enhancing anti-tumor effect of Rhizoma paridis saponins by influencing their metabolic profiling in tumors of H22 hepatocarcinoma mice

Pathology Research and Practice

Volumn 211, Issue 12, 2015, Pages 948-954

  Man, Shuli ^a   Chai, Hongyan ^a   Qiu, Peiyu ^a   Liu, Zhen ^a   Fan, Wei ^a   Wang, Jiaming ^a   Gao, Wenyuan ^a,b  

^a TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b TIANJIN UNIVERSITY   (China)

Author keywords

1H NMR; Hepatocarcinoma; Metabonomics; Rhizoma paridis saponins; Tumor tissue; Turmeric

Indexed keywords

ALANINE; ARABINOSE; ASPARAGINE; CARBOHYDRATE; GLUTAMINE; INOSITOL; LIPID; PUTRESCINE; RHIZOMA PARIDIS SAPONIN; SAPONIN DERIVATIVE; SARCOSINE; TURMERIC; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; PLANT EXTRACT; SAPONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; INFLAMMATORY CELL; LIVER CELL CARCINOMA; METABOLIC REGULATION; MOUSE; MOUSE MODEL; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; TREATMENT DURATION; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR MODEL; ANIMAL; CURCUMA; DISEASE MODEL; LIVER TUMOR; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PHYTOTHERAPY; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; RHIZOME;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CURCUMA; DISEASE MODELS, ANIMAL; FEMALE; LIVER NEOPLASMS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; PHYTOTHERAPY; PLANT EXTRACTS; PRINCIPAL COMPONENT ANALYSIS; RHIZOME; SAPONINS;

EID: 84983111527     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2015.09.011     Document Type: Article

References (35)

1. Chearwae W., Wu C.P., Chu H.Y., Lee T.R., Ambudkar S.V., Limtrakul P. Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1). Cancer Chemother. Pharmacol. 2006, 57:376-388.
2. Gowda G.A. Human bile as a rich source of biomarkers for hepatopancreatobiliary cancers. Biomarkers Med. 2010, 4:299-314.
3. Hirayama A., Kami K., Sugimoto M., Sugawara M., Toki N., Onozuka H., Kinoshita T., Saito N., Ochiai A., Tomita M., Esumi H., Soga T. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res. 2009, 69:4918-4925.
4. Jain M., Nilsson R., Sharma S., Madhusudhan N., Kitami T., Souza A.L., Kafri R., Kirschner M.W., Clish C.B., Mootha V.K. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science (New York, N.Y.) 2012, 336:1040-1044.
5. Jain R.K. Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. Cancer Cell 2014, 26:605-622.
6. Kersemans V., Cornelissen B., Kersemans K., Bauwens M., Achten E., Dierckx R.A., Mertens J., Slegers G. In vivo characterization of 123/125I-2-iodo-l-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT. J. Nucl. Med. 2005, 46:532-539.
7. 1H NMR spectroscopic investigation. NMR Biomed. 2005, 18:371-382.
8. Lim C.B., Ky N., Ng H.M., Hamza M.S., Zhao Y. Curcuma wenyujin extract induces apoptosis and inhibits proliferation of human cervical cancer cells in vitro and in vivo. Integr. Cancer Ther. 2010, 9:36-49.
9. Liu Z., Gao W., Man S., Wang J., Li N., Yin S., Wu S., Liu C. Pharmacological evaluation of sedative-hypnotic activity and gastro-intestinal toxicity of Rhizoma paridis saponins. J. Ethnopharmacol. 2012, 144:67-72.
10. Liu Z., Gao W., Man S., Zhang Y., Li H., Wu S., Zhang J., Liu C. Synergistic effects of Rhizoma paridis and Rhizoma Curcuma longa on different animal tumor models. Environ. Toxicol. Pharmacol. 2014, 38:31-40.
11. Man S., Fan W., Liu Z., Gao W., Li Y., Zhang L., Liu C. Antitumor pathway of Rhizoma paridis saponins based on the metabolic regulatory network alterations in H22 hepatocarcinoma mice. Steroids 2014, 84:17-21.
12. Man S., Gao W., Wei C., Liu C. Anticancer drugs from traditional toxic Chinese medicines. Phytother. Res. 2012, 26:1449-1465.
13. Man S., Gao W., Zhang Y., Jin X., Ma C., Huang X., Li Q. Characterization of steroidal saponins in saponin extract from Paris polyphylla by liquid chromatography tandem multi-stage mass spectrometry. Anal. Bioanal. Chem. 2009, 395:495-505.
14. Man S., Gao W., Zhang Y., Liu Z., Yan L., Huang L., Liu C. Formosanin C-inhibited pulmonary metastasis through repression of matrix metalloproteinases on mouse lung adenocarcinoma. Cancer Biol. Ther. 2011, 11:592-598.
15. Man S., Gao W., Zhang Y., Yan L., Ma C., Liu C., Huang L. Antitumor and antimetastatic activities of Rhizoma paridis saponins. Steroids 2009, 74:1051-1056.
16. Man S., Li Y., Fan W., Gao W., Liu Z., Li N., Zhang Y., Liu C. Curcuma increasing antitumor effect of Rhizoma paridis saponins through absorptive enhancement of paridis saponins. Int. J. Pharm. 2013, 454:296-301.
17. Martin K., Muller P., Schreiner J., Prince S.S., Lardinois D., Heinzelmann-Schwarz V.A., Thommen D.S., Zippelius A. The microtubule-depolymerizing agent ansamitocin P3 programs dendritic cells toward enhanced anti-tumor immunity. Cancer Immunol. Immunother.: CII 2014, 63:925-938.
18. Metallo C.M. Expanding the reach of cancer metabolomics. Cancer Prev. Res. (Philadelphia, PA) 2012, 5:1337-1340.
19. Mitsuishi Y., Taguchi K., Kawatani Y., Shibata T., Nukiwa T., Aburatani H., Yamamoto M., Motohashi H. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 2012, 22:66-79.
20. Montrose D.C., Zhou X.K., Kopelovich L., Yantiss R.K., Karoly E.D., Subbaramaiah K., Dannenberg A.J. Metabolic profiling, a noninvasive approach for the detection of experimental colorectal neoplasia. Cancer Prev. Res. (Philadelphia, PA) 2012, 5:1358-1367.
21. Murphy R.A., Bureyko T.F., Mourtzakis M., Chu Q.S., Clandinin M.T., Reiman T., Mazurak V.C. Aberrations in plasma phospholipid fatty acids in lung cancer patients. Lipids 2012, 47:363-369.
22. Reutter M., Emons G., Grundker C. Starving tumors: inhibition of glycolysis reduces viability of human endometrial and ovarian cancer cells and enhances antitumor efficacy of GnRH receptor-targeted therapies. Int. J. Gynecol. Cancer 2013, 23:34-40.
23. Robert O., Sabatier J., Desoubzdanne D., Lalande J., Balayssac S., Gilard V., Martino R., Malet-Martino M. pH optimization for a reliable quantification of brain tumor cell and tissue extracts with (1)H NMR: focus on choline-containing compounds and taurine. Anal. Bioanal. Chem. 2011, 399:987-999.
24. Roongta U.V., Pabalan J.G., Wang X., Ryseck R.P., Fargnoli J., Henley B.J., Yang W.P., Zhu J., Madireddi M.T., Lawrence R.M., Wong T.W., Rupnow B.A. Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy. Mol. Cancer Res. 2011, 9:1551-1561.
25. Rysman E., Brusselmans K., Scheys K., Timmermans L., Derua R., Munck S., Van Veldhoven P.P., Waltregny D., Daniels V.W., Machiels J., Vanderhoydonc F., Smans K., Waelkens E., Verhoeven G., Swinnen J.V. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. Cancer Res. 2010, 70:8117-8126.
26. Santos C.R., Schulze A. Lipid metabolism in cancer. FEBS J. 2012, 279:2610-2623.
27. Skill N.J., Scott R.E., Wu J., Maluccio M.A. Hepatocellular carcinoma associated lipid metabolism reprogramming. J. Surg. Res. 2011, 169:51-56.
28. Somashekar B.S., Amin A.G., Rithner C.D., Troudt J., Basaraba R., Izzo A., Crick D.C., Chatterjee D. Metabolic profiling of lung granuloma in Mycobacterium tuberculosis infected guinea pigs: ex vivo 1H magic angle spinning NMR studies. J. Proteome Res. 2011, 10:4186-4195.
29. Somashekar B.S., Kamarajan P., Danciu T., Kapila Y.L., Chinnaiyan A.M., Rajendiran T.M., Ramamoorthy A. Magic angle spinning NMR-based metabolic profiling of head and neck squamous cell carcinoma tissues. J. Proteome Res. 2011, 10:5232-5241.
30. Wang J., Zhang S., Li Z., Yang J., Huang C., Liang R., Liu Z., Zhou R. (1)H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis. Tumour Biol. 2011, 32:223-231.
31. Wang X., Fu X., Van Ness C., Meng Z., Ma X., Huang W. Bile acid receptors and liver cancer. Curr. Pathobiol. Rep. 2013, 1:29-35.
32. Wang Y.C., Tang F.Y., Chen S.Y., Chen Y.M., Chiang E.P. Glycine-N methyltransferase expression in HepG2 cells is involved in methyl group homeostasis by regulating transmethylation kinetics and DNA methylation. J. Nutr. 2011, 141:777-782.
33. Wu S., Gao W., Qiu F., Man S., Fu S., Liu C. Simultaneous quantification of Polyphyllin D and Paris H, two potential antitumor active components in Paris polyphylla by liquid chromatography-tandem mass spectrometry and the application to pharmacokinetics in rats. J. Chromatogr. 2012, 905:54-60.
34. Zhang F., Du G. Dysregulated lipid metabolism in cancer. World J. Biol. Chem. 2012, 3:167-174.
35. Zhou W., Capello M., Fredolini C., Racanicchi L., Piemonti L., Liotta L.A., Novelli F., Petricoin E.F. Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells. J. Proteome Res. 2012, 11:554-563.